RVL-1201 Vehicle Placebo

DRUG2 trials

Sponsors

RVL Pharmaceuticals, Inc.

Conditions

Acquired BlepharoptosisBlepharoptosis

Phase 1

Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis

CompletedNCT01848041

RVL Pharmaceuticals, Inc.Blepharoptosis

Start: 2013-05-31End: 2014-02-28Updated: 2021-11-26

Phase 3

Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis

CompletedNCT02436759

RVL Pharmaceuticals, Inc.Acquired Blepharoptosis

Start: 2015-05-31End: 2016-11-30Updated: 2021-10-28